SERUM MAP-TAU IN TRAUMATIC BRAIN INJURY
SERUM MAP-TAU IN TRAUMATIC BRAIN INJURY
批准号:
6071321
负责人:
FRANK P ZEMLAN
金额:
$10.71万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2000
资助国家:
美国
项目状态:
已结题
起止时间:
2000-07-15 至 2001-01-14
中文摘要
该I期申请的目的是开发用于急性神经元变性的基于血清的生物标志物。该测试需要评估包括创伤性脑损伤(TBI)在内的几种临床适应症,以及评估神经保护剂疗效的替代终点。我们已经开发了一种夹心ELISA,用于定量从受损神经元释放的神经定位蛋白MAP-tau。采用这种MAP-tau ELISA,我们已经表明TBI患者的MAP-tau脑脊液(CSF)水平升高10,000倍。在初步研究中,我们证明,血清MAP-tau水平升高40倍,在TBI患者相比,对照组。拟议的研究将评估通过定量血清MAP-tau水平来测量TBI患者中神经元损伤的临床可行性。具体目标是:具体目标1:确定与神经系统对照(N = 30)和非神经系统对照(N=30)相比,TBI患者(N= 30)的血清MAP-tau水平是否升高。具体目的2:确定TB 1患者(N=15)中升高的血清MAP-tau水平的时间过程。具体目标3:确定血清MAP-tau的升高是否与通过受损的血脑屏障扩散到血液中的CSF MAP-tau的损伤相关升高相关。拟定的商业应用:本I期申请的目的是开发一种基于血清的急性神经元变性生物标志物。需要该试验来评估包括创伤性脑损伤(TBI)在内的几种临床适应症,以及评估神经保护剂疗效的替代终点。
英文摘要
The objective of this Phase I application is to develop a serum-based biomarker for acute neuronal degeneration. This test is needed to assess several clinical indications including traumatic brain injury (TBI), as well as, a surrogate endpoint for assessing the efficacy of neuroprotective agents. We have developed a sandwich ELISA for quantifying a neuronally localized protein, MAP-tau, that is released from damaged neurons. Employing this MAP-tau ELISA, we have shown that MAP-tau cerebrospinal fluid (CSF) levels are elevate 10,000 fold in TBI patients. In preliminary studies, we demonstrate that serum MAP-tau levels are elevated 40 fold in TBI patients compared to controls. The proposed studies will assess the clinical feasibility of measuring neuronal damage in TBI patients by quantifying serum MAP- tau levels. The Specific Aims are: Specific Aim 1: Determine if serum MAP-tau levels are elevated in TBI patients (N=30) compared to neurologic controls (N=30) and non-neurologic controls (N=30). Specific Aim 2: Determine the time course of elevated serum MAP-tau levels in TBl patients (N=15). Specific Aim 3: Determine if the elevation of serum MAP-tau is associated with an injury-related elevation in CSF MAP-tau that diffuses into blood via a compromised blood brain barrier. PROPOSED COMMERCIAL APPLICATIONS: The objective of this Phase I application is to develop a serum-based biomarker for acute neuronal degeneration. This test is needed to assess several clinical indications including traumatic brain injury (TBl), as well as, a surrogate endpoint for assessing the efficacy of neuroprotective agents.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
COCAINE THERAPEUTIC: PD2005 DOPAMINE TRANSPORT INHIBITOR
-
批准号:6785636
-
项目类别:
-
资助金额:$13.65万
-
财政年份:2004
-
负责人:FRANK P ZEMLAN
-
依托单位:
Serum C-tau Precition of Brain Damage in Mild TBI
-
批准号:6689352
-
项目类别:
-
资助金额:$12.86万
-
财政年份:2003
-
负责人:FRANK P ZEMLAN
-
依托单位:
Biomarker for Subarachnoid Hemorrhage
-
批准号:6483618
-
项目类别:
-
资助金额:$12.81万
-
财政年份:2002
-
负责人:FRANK P ZEMLAN
-
依托单位:
Melatonin Analog for Sleep Disorders
-
批准号:6712083
-
项目类别:
-
资助金额:$46.32万
-
财政年份:2002
-
负责人:FRANK P ZEMLAN
-
依托单位:
Melatonin Analog for Sleep Disorders
-
批准号:6707905
-
项目类别:
-
资助金额:$50.43万
-
财政年份:2002
-
负责人:FRANK P ZEMLAN
-
依托单位:
Biomarker of Neuronal Damage in Traumatic Brain Injury
-
批准号:6598070
-
项目类别:
-
资助金额:$23.69万
-
财政年份:2001
-
负责人:FRANK P ZEMLAN
-
依托单位:
Biomarker of Neuronal Damage in Traumatic Brain Injury
-
批准号:6612652
-
项目类别:
-
资助金额:$25.73万
-
财政年份:2001
-
负责人:FRANK P ZEMLAN
-
依托单位:
Biomarker of Neuronal Damage in Traumatic Brain Injury
-
批准号:6650523
-
项目类别:
-
资助金额:$4.08万
-
财政年份:2001
-
负责人:FRANK P ZEMLAN
-
依托单位:
Biomarker of Neuronal Damage in Traumatic Brain Injury
-
批准号:6529679
-
项目类别:
-
资助金额:$27.07万
-
财政年份:2001
-
负责人:FRANK P ZEMLAN
-
依托单位:
Neurotoxin Discovery Platform - Drugs of Abuse
-
批准号:6743783
-
项目类别:
-
资助金额:$24.31万
-
财政年份:2000
-
负责人:FRANK P ZEMLAN
-
依托单位:
Neurotoxin Discovery Platform - Drugs of Abuse
-
批准号:6626012
-
项目类别:
-
资助金额:$23.6万
-
财政年份:2000
-
负责人:FRANK P ZEMLAN
-
依托单位:
NEUROTOXIN DISCOVERY PLATFORM - DRUGS OF ABUSE
-
批准号:6135366
-
项目类别:
-
资助金额:$10.8万
-
财政年份:2000
-
负责人:FRANK P ZEMLAN
-
依托单位:
Neurotoxin Discovery Platform - Drugs of Abuse
-
批准号:6484021
-
项目类别:
-
资助金额:$26.18万
-
财政年份:2000
-
负责人:FRANK P ZEMLAN
-
依托单位:
HUMAN SERUM BIOMARKER FOR NEUROTOXICITY
-
批准号:6210766
-
项目类别:
-
资助金额:$10.48万
-
财政年份:2000
-
负责人:FRANK P ZEMLAN
-
依托单位:
CSF MAP-2 IN TRAUMATIC BRAIN INJURY
-
批准号:2793074
-
项目类别:
-
资助金额:$10.0万
-
财政年份:1999
-
负责人:FRANK P ZEMLAN
-
依托单位:
CSF AND PLASMA NEUROFILAMENTS IN TRAUMATIC BRAIN INJURY
-
批准号:6015713
-
项目类别:
-
资助金额:$10.0万
-
财政年份:1999
-
负责人:FRANK P ZEMLAN
-
依托单位:
DOPAMINE FUNCTIONAL SUBTYPES OF SCHIZOPHRENIA
-
批准号:3378322
-
项目类别:
-
资助金额:$16.71万
-
财政年份:1986
-
负责人:FRANK P ZEMLAN
-
依托单位:
DOPAMINE FUNCTIONAL SUBTYPES OF SCHIZOPHRENIA
-
批准号:3378320
-
项目类别:
-
资助金额:$15.44万
-
财政年份:1986
-
负责人:FRANK P ZEMLAN
-
依托单位:
DOPAMINE FUNCTIONAL SUBTYPES OF SCHIZOPHRENIA
-
批准号:3378321
-
项目类别:
-
资助金额:$16.47万
-
财政年份:1986
-
负责人:FRANK P ZEMLAN
-
依托单位:
PEPTIDE/MONOAMINE CONTROL OF SPINAL PAIN TRANSMISSION
-
批准号:3398369
-
项目类别:
-
资助金额:$11.69万
-
财政年份:1983
-
负责人:FRANK P ZEMLAN
-
依托单位:
海外基金